Sorrento Therapeutics, Inc.
SRNE
SRNE was delisted on the 22nd of February, 2023.
234 hedge funds and large institutions have $433M invested in Sorrento Therapeutics, Inc. in 2021 Q4 according to their latest regulatory filings, with 53 funds opening new positions, 72 increasing their positions, 58 reducing their positions, and 37 closing their positions.
97% more call options, than puts
Call options by funds: $48.9M | Put options by funds: $24.9M
43% more first-time investments, than exits
New positions opened: 53 | Existing positions closed: 37
24% more repeat investments, than reductions
Existing positions increased: 72 | Existing positions reduced: 58
6% more funds holding
Funds holding: 220 → 234 (+14)
34% less capital invested
Capital invested by funds: $658M → $433M (-$225M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
+$14.3M |
| 2 |
BlackRock
New York
|
+$5.64M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$4.81M |
| 4 |
JP Morgan Chase
New York
|
+$3.97M |
| 5 |
SM
Sabby Management
Miami Beach,
Florida
|
+$3.05M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
D.E. Shaw & Co
New York
|
-$3.14M |
| 2 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$3.05M |
| 3 |
State of New Jersey Common Pension Fund D
Trenton,
New Jersey
|
-$2.44M |
| 4 |
First Trust Advisors
Wheaton,
Illinois
|
-$2.16M |
| 5 |
Schroder Investment Management Group
London,
United Kingdom
|
-$2.12M |
SRNE Hedge Fund Activity: Q4 2021 in Review
234 of the 6,518 institutional investors tracked by Wall St. Rank reported a position in Sorrento Therapeutics, Inc. (SRNE) for Q4 2021, worth a combined $433M — down 34% from $658M a quarter earlier.
Buyers outnumbered sellers: 53 funds opened new SRNE positions and 37 closed out — a net gain of 16 holders — while 72 added to existing stakes and 58 trimmed.
The largest buyer was State Street, adding an estimated $14.3M. The largest seller was D.E. Shaw & Co, cutting an estimated $3.14M.
- 234 institutional investors held Sorrento Therapeutics, Inc. (SRNE) as of Q4 2021, up from 220 in Q3 2021.
- Funds reported $433M of Sorrento Therapeutics, Inc. stock for Q4 2021, down 34% quarter-over-quarter.
- 53 funds opened new Sorrento Therapeutics, Inc. positions in Q4 2021 and 37 closed out, a net change of +16 holders.
- The largest Sorrento Therapeutics, Inc. buyer in Q4 2021 was State Street, an estimated $14.3M added.
- The largest Sorrento Therapeutics, Inc. seller in Q4 2021 was D.E. Shaw & Co, an estimated $3.14M sold.
Based on aggregated 13F filings for Q4 2021.